Stocks
Medpace Holdings, Inc.MEDP
NASDAQHealthcareBiotechnology$450.41+1.48%
A clinical research organization (CRO) providing outsourced services for drug and medical device development, Medpace Holdings supports biopharmaceutical and biotechnology firms globally. The company is known for its full-service model spanning Phase I-IV clinical trials, attracting investor attention as a key player in the growing CRO market. Its performance is often viewed as a barometer for R&D spending trends in the biopharma sector.
Market Cap: $12.8B52W Range: $250.05 – $628.92
Congressional Interest in Medpace Holdings, Inc. (MEDP)
7 members of Congress have disclosed 24 trades in Medpace Holdings, Inc. (MEDP), a Healthcare company. The buy/sell breakdown shows 11 purchases versus 13 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
24
Unique Politicians
7
Buys
11
Sells
13
Who in Congress Is Trading MEDP?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2026-02-26 | David Taylor | buy | $1K – $15K |
| 2026-01-29 | David Taylor | buy | $1K – $15K |